ÂÜÀòÂÒÂ×

Carlos Moscol is a highly experienced strategic advisor and consultant in the biotech and pharmaceutical sectors, currently serving as a Strategic Advisor at AmerStem Inc. since May 2022. With a robust background at Pfizer from 2009 to 2020, Carlos held multiple vice president roles, leading significant sales and marketing efforts for various blockbuster products, including Vyndamax and Xeljanz. Additionally, Carlos has advised Gavi, the Vaccine Alliance, on COVAX operations from January 2022 to December 2023, specifically managing high-level government engagements. Early career experience includes key positions at Wyeth BioPharma, where Carlos led substantial marketing and sales operations across different regions. Carlos holds a B.S. in Business Administration from Universidad Metropolitana in Venezuela.